Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.030 GeneticVariation disease BEFREE Distribution of and correlation between histologic abnormalities, DNA content, and loss of heterozygosity for a p53 allele (p53 LOH) in the colons of nine UC patients were analyzed. 1358743 1992
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.030 GeneticVariation disease BEFREE We have examined the frequency of allelic loss of the p53 gene in carcinoma and dysplasia arising in patients with chronic ulcerative colitis who are heterozygous for the codon 72 polymorphism in exon 4 of the p53 gene. 2049225 1991
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.030 Biomarker disease BEFREE It appears that aneuploidy is linked with specific gene mutations, i.e., of the tumour suppressor gene p53 in chronic ulcerative colitis and in Barrett's esophagus, and of the protooncogene K-ras in colorectal adenomas. 9413595 1997
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.010 Biomarker disease BEFREE Therefore, the purpose of this study was to evaluate loss of heterozygosity (LOH) of 3p, APC, and p16 in a specific group of CUC-associated "adenoma-like" DALMs and to compare the results of this tumor with those in a well-defined group of CUC-associated non-adenoma-like DALMs and non-CUC-associated sporadic adenomas. 10976694 2000
Entrez Id: 324
Gene Symbol: APC
APC
0.010 Biomarker disease BEFREE Therefore, the purpose of this study was to evaluate loss of heterozygosity (LOH) of 3p, APC, and p16 in a specific group of CUC-associated "adenoma-like" DALMs and to compare the results of this tumor with those in a well-defined group of CUC-associated non-adenoma-like DALMs and non-CUC-associated sporadic adenomas. 10976694 2000
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
0.010 Biomarker disease BEFREE Therefore, the purpose of this study was to evaluate loss of heterozygosity (LOH) of 3p, APC, and p16 in a specific group of CUC-associated "adenoma-like" DALMs and to compare the results of this tumor with those in a well-defined group of CUC-associated non-adenoma-like DALMs and non-CUC-associated sporadic adenomas. 10976694 2000
Entrez Id: 373156
Gene Symbol: GSTK1
GSTK1
0.010 AlteredExpression disease BEFREE GST-3H-trans-stilbene oxide activity was detected in all tissues except 1/13 (7.6%) CUC tissues and 7/14 (50.0%, P<or=0.05) colorectal adenocarcinomas. 11809532 2002
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.010 AlteredExpression disease BEFREE GST-3H-trans-stilbene oxide activity was detected in all tissues except 1/13 (7.6%) CUC tissues and 7/14 (50.0%, P<or=0.05) colorectal adenocarcinomas. 11809532 2002
Entrez Id: 27034
Gene Symbol: ACAD8
ACAD8
0.010 Biomarker disease BEFREE Crohn's and chronic ulcerative colitis- collectively known as inflammatory bowel disease [IBD]) are a very significant public health problem in the United States and other industrialized nations. 12664590 2002
Entrez Id: 567
Gene Symbol: B2M
B2M
0.010 Biomarker disease BEFREE The interleukin (IL) 2- and beta(2)-microglobulin (beta(2)m)-deficient (IL-2(null) x beta(2)m(null)) mice spontaneously develop colon cancer in the setting of chronic UC. 14652292 2003
Entrez Id: 3558
Gene Symbol: IL2
IL2
0.010 Biomarker disease BEFREE These data indicate that dietary folate supplementation at 4x the basal dietary requirement significantly suppresses UC-associated colorectal carcinogenesis in the IL-2(null) x beta(2)m(null) mice. 14652292 2003
Entrez Id: 2070
Gene Symbol: EYA4
EYA4
0.010 PosttranslationalModification disease BEFREE EYA4 methylation represents a candidate marker for CUC surveillance. 16469682 2006
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.030 Biomarker disease BEFREE Reductions in P-beta-catenin in CUC biopsy specimens with severe inflammation suggested that mesalamine reduced P-beta-catenin levels in tissue refractory to mesalamine's anti-inflammatory effects. 19879273 2010
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.030 AlteredExpression disease BEFREE Human samples had increased numbers of progenitor cells with P-beta-catenin(552) throughout expanded crypts and increased messenger RNA expression of beta-catenin target genes in CUC, colitis-associated cancer, tubular adenomas, and sporadic colorectal cancer, compared with control samples. 20580720 2010
Entrez Id: 788
Gene Symbol: SLC25A20
SLC25A20
0.010 Biomarker disease BEFREE PI3K-induced and Akt-mediated beta-catenin signaling are required for progenitor cell activation during the progression from CUC to CAC; these factors might be used as biomarkers of dysplastic transformation in the colon. 20580720 2010
Entrez Id: 5293
Gene Symbol: PIK3CD
PIK3CD
0.010 Biomarker disease BEFREE PI3K-induced and Akt-mediated beta-catenin signaling are required for progenitor cell activation during the progression from CUC to CAC; these factors might be used as biomarkers of dysplastic transformation in the colon. 20580720 2010
Entrez Id: 760
Gene Symbol: CA2
CA2
0.010 Biomarker disease BEFREE PI3K-induced and Akt-mediated beta-catenin signaling are required for progenitor cell activation during the progression from CUC to CAC; these factors might be used as biomarkers of dysplastic transformation in the colon. 20580720 2010
Entrez Id: 5291
Gene Symbol: PIK3CB
PIK3CB
0.010 Biomarker disease BEFREE PI3K-induced and Akt-mediated beta-catenin signaling are required for progenitor cell activation during the progression from CUC to CAC; these factors might be used as biomarkers of dysplastic transformation in the colon. 20580720 2010
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
0.010 Biomarker disease BEFREE PI3K-induced and Akt-mediated beta-catenin signaling are required for progenitor cell activation during the progression from CUC to CAC; these factors might be used as biomarkers of dysplastic transformation in the colon. 20580720 2010
Entrez Id: 5294
Gene Symbol: PIK3CG
PIK3CG
0.010 Biomarker disease BEFREE PI3K-induced and Akt-mediated beta-catenin signaling are required for progenitor cell activation during the progression from CUC to CAC; these factors might be used as biomarkers of dysplastic transformation in the colon. 20580720 2010
Entrez Id: 6869
Gene Symbol: TACR1
TACR1
0.010 AlteredExpression disease BEFREE In this study, archival formalin-fixed paraffin-embedded colonic tissue from patients with UC who developed carcinoma (CA) or high-grade dysplasia (HGD) was examined for changes in expression of the proinflammatory and mitogenic neurokinin-1 receptor (NK-1R). 21969570 2011
Entrez Id: 6863
Gene Symbol: TAC1
TAC1
0.010 AlteredExpression disease BEFREE In this study, archival formalin-fixed paraffin-embedded colonic tissue from patients with UC who developed carcinoma (CA) or high-grade dysplasia (HGD) was examined for changes in expression of the proinflammatory and mitogenic neurokinin-1 receptor (NK-1R). 21969570 2011
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.030 AlteredExpression disease BEFREE Reduced PI3K/Akt signaling and expression of β-catenin target genes in 5-ASA-treated CUC patients additionally suggests enhanced PTEN activity as well. 23867870 2013
Entrez Id: 847
Gene Symbol: CAT
CAT
0.010 AlteredExpression disease BEFREE Analysis of biopsies from patient samples revealed that 5-ASA increases expression of the antioxidant catalase in CUC patients. 23867870 2013
Entrez Id: 410
Gene Symbol: ARSA
ARSA
0.010 AlteredExpression disease BEFREE Analysis of biopsies from patient samples revealed that 5-ASA increases expression of the antioxidant catalase in CUC patients. 23867870 2013